welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
healthcare providers
Frank A. Sinicrope, MD
Healthcare Provider Professor of Oncology, Medicine
Mayo Clinic Rochester
200 1st St SW
Places : Mayo Clinic Dana-Farber Cancer Institute
Interests:
Colorectal cancer prevention and therapy of established disease
Education:
Fellowship: Medical Oncology, University of Texas M.D. Anderson Cancer Center
Fellowship: Gastroenterology, National Institutes of Health Research Fellow, University of Chicago
Fellowship: Gastroenterology/Hepatology, University of Chicago Hospitals
MD: University of Chicago Pritzker School of Medicine
Representative Publications:
Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients
expertly curated content related to this topic
- Luca Stocchi, MDLuca Stocchi is a Surgeon and Chair in t...
- Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous P...RATIONALE: Chemoprevention is the us...
- Ursodeoxycholic Acid Counteracts Celecoxib in Reduction of Duodenal Polyps in Patients With Familial Adenomatous Pol...BACKGROUND: Due to prophylactic colecto...
- Robert E. Schoen, MD, MPHRobert E. Schoen, MD, MPH is Professor o...
- Steven H. Erdman, MDSteven H. Erdman, MD, is a pediatric gas...
- James HillMr James Hill is Clinical Professor of C...
- Andrew Goodwin, PhDCommitted to contributing to the efficie...